Osthole Increases the Sensitivity of Liver Cancer to Sorafenib by Inhibiting Cholesterol Metabolism-Reference-Cited by-同舟云学术

Osthole Increases the Sensitivity of Liver Cancer to Sorafenib by Inhibiting Cholesterol Metabolism

Published:2022-06-15 Issue:10 Volume:74 Page:3640-3650
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Fan Ke¹,Huang Hui¹,Zhao Ying¹²,Xie Tao³,Zhu Zeng-Yan²,Xie Mei-Lin¹^ORCID

Affiliation:

1. Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu Province, China

2. Department of Pharmacy, Children’s Hospital of Soochow University, Suzhou, Jiangsu Province, China

3. Department of Neurosurgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu Province, China

Funder

Science & Technology Project of Suzhou City for Medical Health

Research Program of Gusu School of Nanjing Medical University

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2022.2087885

Reference23 articles.

1. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis

2. Sorafenib prevents the proliferation and induces the apoptosis of liver cancer cells by regulating autophagy and hypoxia-inducible factor-1

3. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy

4. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma

5. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice;Strahlentherapie und Onkologie;2023-11-14